Bharat Biotech is on the threshold of becoming the second Indian vaccine maker to receive an emergency use approval in the domestic market for a children’s Covid vaccine. The company’s vaccine, Covaxin, is already in...
from Times of India Opinion https://ift.tt/2XcL35q
No comments:
Post a Comment